LINDA is a platform that utilizes artificial intelligence and infrared imaging to detect early warning signs of breast cancer through a non-invasive, contactless method. This technology enables rapid analysis and results, improving access to screenings for women who may not have previously undergone breast cancer testing.
Funding
$564.7K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
KVPAFounders
Product
Problem
Traditional breast cancer screening methods like mammography can be invasive, involve radiation exposure, and may not be easily accessible for all women, leading to delayed or missed diagnoses. Many women, particularly in underserved communities, may not have regular access to these screening services.
Solution
LINDA offers a non-invasive, contactless breast cancer screening platform that utilizes artificial intelligence and infrared imaging to detect early warning signs. The technology analyzes thermal patterns in breast tissue to identify potential abnormalities, providing rapid results in seconds. This approach aims to improve access to breast cancer screenings, especially for women who may not have previously undergone testing or who prefer a non-invasive method. The platform is designed to be simple to use, enabling broader deployment in various healthcare settings.
Target Audience
The primary target audience includes women seeking accessible and non-invasive breast cancer screening options, as well as healthcare providers looking to expand their screening capabilities and reach underserved populations.
Features
- AI-powered analysis of infrared breast images for rapid detection of potential abnormalities
- Contactless and radiation-free screening process
- Fast results available in seconds
- Designed for ease of use and accessibility in diverse healthcare settings
- Currently available to over 3 million women